BlackRock, Inc. 13D and 13G filings for Alaunos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-07-08 4:56 pm Sale | 2022-06-30 | 13G | Alaunos Therapeutics, Inc. TCRT | BlackRock Inc. BLK | 34,919 2.400% | -76,848 (-68.76%) | Filing |
| 2022-02-02 7:11 pm Sale | 2021-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT | BlackRock Inc. BLK | 111,766 7.800% | -11,969 (-9.67%) | Filing |
| 2021-02-01 08:23 am Purchase | 2020-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT | BlackRock Inc. BLK | 123,736 8.700% | 40,457 (+48.58%) | Filing |